Many more asthma sufferers stand to benefit from biologics but have not yet been put into the right referral pathways.
The issue isn’t around medication hesitancy, but more a gap of knowledge regarding the general awareness of the availability of this medication and the recognition of patients who might benefit from its use, says Dr Greg Katsoulotos.
This is an area that respiratory physicians themselves struggle with, he says.
Listen to expert interviews.
Click to open in a new tab
Browse the latest articles from Healthed.
You have completed the Educational Activities component of this resource.
Select ‘Confirm & claim CPD‘ to confirm you have engaged with this resource in its entirety and claim your CPD.
You will be taken to explore further CPD learning available to you.
